04/13/2026
A nine-month-old from Philadelphia born with a rare genetic disorder faced a life-threatening build-up of ammonia that risked permanent brain damage. Because his liver could not process toxic waste, doctors had a narrow window to intervene before the condition became irreversible.
In a groundbreaking feat of precision medicine, scientists developed a personalized CRISPR gene-editing therapy for the infant in just six months. The treatment was injected directly into his bloodstream, where it successfully targeted and corrected the specific genetic mutation responsible for the disorder.
Following the procedure, the patient began processing ammonia normally and is now reaching developmental milestones once thought impossible. This successful case demonstrates the transformative potential of rapid, customized gene editing to treat previously incurable genetic diseases.